NASDAQ : APTO

Aptose Biosciences Inc. — Institutional Ownership

$1.71 USD

$1.71 (0%)

Volume
648.21K
Average Volume
223.28K
Market Capitalization
$4.36M
P/E Ratio
-0.65
Dividend Yield
0.00%
Price Target
Year High
$43.19
Year Low
$1.10
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.55
Institutional Ownership Summary
Institutional Ownership %

%

Investors Holding

change: 0.0 | last:
Increased Positions

change: 0.0 | last:
Reduced Positions

change: 0.0 | last:
New Positions

change: 0.0 | last:
Sold Positions

change: 0.0 | last:
Total Calls

-

Total Puts

-

Put-Call Ratio

change: 0.0 | last:
Total Invested

-

Beneficial Ownership Filings
Filing Date Reporting Person Amount Beneficially Owned % of Class
2025-08-14 Bleichroeder LP 41666.0 1.61%
2025-05-13 Bleichroeder LP 163.03K 6.30%
2025-03-24 Bleichroeder LP 163.03K 7.50%
2025-03-21 Bleichroeder LP 3.75M 6.20%
2025-03-20 Hanmi Pharmaceutical Co., Ltd. 508.71K 19.90%
2025-02-14 Armistice Capital, LLC 1.03M 4.99%
2025-02-13 Bleichroeder LP 3.75M 6.20%
2024-11-14 Steven Boyd 1.96M 9.99%
2024-11-14 Armistice Capital, LLC 1.96M 9.99%
2023-09-12 Pharmaceutical Co., Ltd. 884.15K 12.07%
2023-01-17 Vanman Charitable Foundation 200K 0.20%
2023-01-17 Bios Capital Management, LP 5.11M 5.50%
2023-01-17 LLC 250K 0.30%
2023-01-17 Joseph O’Donnell 100000.0 0.11%
2023-01-17 the Arts and Education 124.1K 0.10%
2023-01-17 Robert Vernon Vanman 200K 0.20%
2023-01-17 Bios Equity Partners SOF I, LP 4.24M 4.60%
2023-01-17 LP 925.04K 0.11%
2023-01-17 Bios Special Opportunity Fund, LP 3.31M 3.60%
2023-01-17 Bios Advisors GP, LLC 5.11M 5.50%
2023-01-17 Aaron G.L. Fletcher 6.25M 6.77%
2022-02-14 Wilmot B. Harkey 7.6M 8.50%
2022-02-14 Daniel Mack 7.6M 8.50%
2022-02-14 Nantahala Capital Management, LLC 7.6M 8.50%
2022-02-11 OrbiMed Capital LLC - 0.00%
2021-08-10 DRW Investments, LLC 8.89M 9.99%
2021-02-17 Consonance Capman GP LLC - 0.00%
2021-02-17 Mitchell Blutt - 0.00%
2021-02-17 Consonance Capital Opportunity Fund Management LP - 0.00%
2021-02-17 Consonance Capital Management LP - 0.00%
2021-02-16 Consonance Capman GP LLC 6.06M 9.99%
2021-02-16 Mitchell Blutt - 0.00%
2021-02-16 Consonance Capital Opportunity Fund Management LP - 0.00%
2021-02-16 Consonance Capital Opportunity Fund Management LP 1.19M 2.04%
2021-02-16 Mitchell Blutt 6.06M 9.99%
2021-02-16 Consonance Capman GP LLC - 0.00%
2021-02-16 Consonance Capital Management LP - 0.00%
2021-02-16 Consonance Capital Management LP - 0.00%
2021-02-12 Nantahala Capital Management, LLC 7.27M 8.20%
2021-02-12 OrbiMed Capital LLC 8.03M 9.04%
2021-02-12 Daniel Mack 7.27M 8.20%
2021-02-12 Wilmot B. Harkey 7.27M 8.20%
2021-02-01 DRW Investments, LLC 7.97M 8.97%
2021-01-15 Herbert Abramson 3.69M 4.10%
2020-02-14 Daniel Mack 6.05M 8.00%
2020-02-14 Consonance Capital Opportunity Fund Management LP 687.13K 0.90%
2020-02-14 Consonance Capital Management LP 4.09M 5.37%
2020-02-14 Mitchell Blutt 4.77M 6.27%
2020-02-14 Consonance Capman GP LLC 4.77M 6.27%
2020-02-14 Wilmot B. Harkey 6.05M 8.00%
2020-02-14 Nantahala Capital Management, LLC 6.05M 8.00%
2020-02-04 Herbert Abramson 4.11M 5.60%
2019-12-27 Opaleye Management Inc. 9.0 5.52%
2019-02-12 Donald R. Wilson, Jr. 2.47M 6.55%
2019-02-12 DRW Securities, LLC 2.47M 6.55%
2019-01-16 Herbert Abramson 3.72M 9.80%
2018-02-14 Bihua Chen - 0.00%
2018-02-14 Cormorant Asset Management, LLC - 0.00%
2018-02-14 Cormorant Global Healthcare GP, LLC - 0.00%
2018-02-14 Cormorant Global Healthcare Master Fund, LP - 0.00%
2018-02-14 Laurence W.Lytton 1.78M 6.20%
2018-01-19 Herbert Abramson 2.6M 9.60%
2017-06-09 Laurence W.Lytton 1.19M 5.50%
2017-01-17 Herbert Abramson 1.45M 9.20%
2016-03-29 Herbert Abramson 805.83K 6.70%
2016-02-16 Cormorant Asset Management, LLC 1.08M 9.30%
2016-02-16 Cormorant Global Healthcare GP, LLC 1.08M 9.30%
2016-02-16 Cormorant Global Healthcare Master Fund, LP 1.08M 9.30%
2016-02-16 Bihua Chen 1.08M 9.30%
2015-03-02 Sheldon Inwentash 614.47K 5.30%
2015-02-13 Pinetree Income Partnership 874.3K 7.50%
2015-02-13 Pinetree Capital Ltd. 874.3K 7.50%
2015-02-13 Pinetree Capital Investment Corp. 874.3K 7.50%
2015-02-13 Emerald Capital Corp. 874.3K 7.50%
2015-02-09 Charles B. Johnson 1.42M 12.10%
2014-11-26 Pinetree Capital Ltd. 869.3K 7.50%
2014-11-26 Sheldon Inwentash 1.49M 12.80%
2014-11-26 Emerald Capital Corp. 869.3K 7.50%
2014-11-26 Pinetree Capital Investment Corp. 869.3K 7.50%
2014-11-26 Pinetree Income Partnership 869.3K 7.50%
2014-04-14 Cormorant Global Healthcare GP, LLC 13M 11.50%
2014-04-14 Cormorant Asset Management, LLC 13M 11.50%
2014-04-14 Cormorant Global Healthcare Master Fund, LP 13M 11.50%
2014-04-14 Bihua Chen 13M 11.50%
2013-02-05 (. 1.37M 3.20%
2012-02-14 (. 1.08M 5.00%
2011-02-07 2187792 Ontario Inc. 528.26K 3.40%
2011-02-07 1346049 Ontario Limited 528.26K 3.40%
2011-02-07 Trapeze Asset Management Inc. 528.26K 3.40%
2011-02-07 Trapeze Capital Corp. 528.26K 3.40%
2011-02-07 Randall Abramson 528.26K 3.40%
2011-02-07 William Richard Hermon 1.39M 8.60%
2010-11-16 William Richard Hermon 1.28M 8.70%
2010-04-22 Trapeze Asset Management Inc. 15.44M 5.10%
2010-04-22 2187792 Ontario Inc. 15.44M 5.10%
2010-04-22 Randall Abramson 15.44M 5.10%
2010-04-22 Trapeze Capital Corp. 15.44M 5.10%
2010-04-22 1346049 Ontario Limited 15.44M 5.10%
2007-05-04 High Tech Private Equity GmbH 29.09M 13.70%
2007-05-04 High Tech Beteiligungen GmbH & Co. KG 29.09M 13.70%
2007-05-04 Conpharm Anstalt 29.09M 13.70%
2007-05-04 Georg Ludwig 29.09M 13.70%
2006-02-27 Technifund Inc. 9.52M 5.50%
2006-02-27 Herbert Abramson 9.6M 5.50%
1998-03-24 Connor Clark & Company Ltd. 4.07M 11.00%
1998-03-24 Connor Clark & Company Ltd. 4.07M 11.00%
1997-02-14 Connor, Clark & Company Ltd. 4.99M 11.00%
APTO Enterprise Value History
Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2025-12-31 $1.71 2.45M $4.18M $935K $193K $3.44M
2024-12-31 $6.76 4.44M $30.02M $6.15M $10.64M $34.51M
2023-12-31 $76.20 6.76M $514.73M $9.25M $1.02M $506.49M
2022-12-31 $130.50 6.15M $802.72M $36.97M $1.3M $767.06M
2021-12-31 $303.75 5.94M $1.8B $39.11M $574K $1.76B
2020-12-31 $985.50 5.94M $5.85B $117.39M $1.07M $5.73B
2019-12-31 $1275.75 3.34M $4.27B $79.84M $1.53M $4.19B
2018-12-31 $429.75 2.23M $956.65M $15.3M -$ $941.35M
2017-12-31 $504.00 1.49M $749.72M $10.63M -$ $739.09M
2016-12-31 $312.75 849.53K $265.69M $7.94M -$ $257.75M
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2026-03-31 $1.71 2.55M $4.36M $1.02M $80000 $3.42M
2025-12-31 $1.71 2.45M $4.18M $935K $193K $3.44M
2025-09-30 $1.71 2.55M $4.36M $613K $305K $4.06M
2025-06-30 $2.20 2.55M $5.62M $553K $413K $5.48M
2025-03-31 $3.15 2.13M $6.7M $4.7M $8.98M $10.98M
2024-12-31 $6.76 5.6M $37.84M $6.15M $10.64M $42.33M
2024-09-30 $12.33 5.6M $69.02M $7.96M $10.72M $71.78M
2024-06-30 $22.35 5.6M $125.11M $8.33M $818K $117.6M
2024-03-31 $48.00 5.6M $268.7M $7.35M $919K $262.27M
2023-12-31 $76.20 6.62M $504.82M $9.25M $1.02M $496.59M
2023-09-30 $84.00 6.5M $545.58M $15.72M $1.11M $530.97M
2023-06-30 $139.20 6.23M $867.77M $8.4M $1.2M $860.58M